Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Sana Biotechnology Inc (NASDAQ: SANA) closed at $2.6 in the last session, down -0.38%% from day before closing price of $2.61. In other words, the price has decreased by -$0.38% from its previous closing price. On the day, 16.14 million shares were traded.
Ratios:
We take a closer look at SANA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 14, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $7.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares for $3.16 per share.
CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares of SANA for $289,500 on Jan 16 ’25. On Jan 08 ’25, another insider, FMR LLC, who serves as The insider 1 of the company, sold 290,912 shares for $6.49 each. As a result, the insider received 1,887,320 and left with 4,541,511 shares of the company.
Stock Price History:
Over the past 52 weeks, SANA has reached a high of $7.40, while it has fallen to a 52-week low of $1.26. The 50-Day Moving Average of the stock is 25.93%, while the 200-Day Moving Average is calculated to be -6.91%.
Shares Statistics:
A total of 225.46M shares are outstanding, with a floating share count of 125.44M. Insiders hold about 44.39% of the company’s shares, while institutions hold 51.55% stake in the company.
